---
title: "57 Series B Medtech Investors (Nov 2026)"
last_updated: "2026-11-07"
rows: "57"
free_rows: "25"
source: "SEC Form D filings and our own research"
canonical: "https://theinvestordatabase.com/lists/series-b-medtech-investors/"
---

# 57 Series B medtech investors

We list 57 Series B medtech investors as of November 2026: 37 have an SEC filing on file and 20 were checked on the firm's own website or an official register, and the list was last checked on 7 Nov 2026. The states with the most are California (9), Massachusetts (5) and Tennessee (3).

- 57 investors
- 32 with a fund filing or dated deal in the last 12 months
- $81M median fund size on file (SEC Form D, 24 firms)
- 296 named decision-makers on file

## First 25 of 57 Series B medtech investors

| Investor | Type | HQ | Stages (our research) | Focus (our research) | Latest fund or deal | Fund size | Checked | Profile |
|---|---|---|---|---|---|---|---|---|
| BGF | VC firm | United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, Edtech, Developer Tools | Portfolio news, Oct 2026 | £3.0B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/bgf/ |
| Claritas Signal Partners | VC firm | Nashville, TN | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Media | New deal, Aug 2026 | $14M (SEC Form D, 2021) | 2026-11-05 | https://theinvestordatabase.com/investors/claritas-signal-partners/ |
| Parkwalk Advisors | SEIS/EIS fund | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Industrial Tech | New fund, Sep 2026 | £500M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/parkwalk/ |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | $2.8B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hbm-partners-ag/ |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Medtech, Biotech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/andera-partners/ |
| FCA Venture Management Group | VC firm | Nashville, TN | Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | Portfolio news, May 2026 | $58M (SEC Form ADV) | 2026-11-05 | https://theinvestordatabase.com/investors/fca-venture-management-group/ |
| Star51 Capital | VC firm | New York, NY | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Robotics | New deal, Sep 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/star51-capital/ |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Medtech, Healthtech, Biotech | New deal, Sep 2026 | €230M (own site) | 2026-11-07 | https://theinvestordatabase.com/investors/hadean-ventures-as/ |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Medtech, Insurtech, Healthtech, AI | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 2026-11-04 | https://theinvestordatabase.com/investors/sandbox-clinical-ventures/ |
| Balderton Capital | VC firm | London, United Kingdom | Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, Fintech | Portfolio news, Oct 2026 | $5.7B (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/balderton-capital/ |
| Cultivation Capital | VC firm | St. Louis, MO | Seed, Series A, Series B | Medtech, Healthtech, Biotech, SaaS | New fund, Sep 2026 | $100M (SEC Form D, 2022) | 2026-11-04 | https://theinvestordatabase.com/investors/cultivation-capital/ |
| Define Ventures | VC firm | San Francisco, CA | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Future of Work | New deal, Apr 2026 | $425M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/define-ventures/ |
| IVP: Venture capital for the Exceptional | VC firm | Menlo Park, CA | Series B, Growth | Medtech, AI, Healthtech, Developer Tools | New fund, Oct 2026 | $60M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/ivp-venture-capital-for-the-exceptional/ |
| Cornucopian Capital | VC firm | Montclair, NJ | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, Biotech | New fund, Aug 2026 | $12M (SEC Form D, 2024) | 2026-11-04 | https://theinvestordatabase.com/investors/cornucopian-capital/ |
| Arboretum Ventures | VC firm | Ann Arbor, MI | Series A, Series B | Medtech, Healthtech, Biotech | Portfolio news, Mar 2026 | $250M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/arboretum-ventures/ |
| Wellington Partners | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, May 2026 | €210M (own site) | 2026-11-04 | https://theinvestordatabase.com/investors/wellington-partners/ |
| Calculus VC | VC firm | Foster City, CA | Series A, Series B | Medtech, AI, Deep Tech, Healthtech | New deal, Aug 2026 | $1M (SEC Form D, 2025) | 2026-11-04 | https://theinvestordatabase.com/investors/calculus-vc/ |
| How Women Invest | VC firm | Oakland, CA | Pre-seed, Seed, Series A, Series B | Medtech, Healthtech, AI, B2B | New fund, Sep 2026 | $12M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/how-women-invest/ |
| 415 Capital | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech | Portfolio news, Nov 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/415-capital-management-gmbh/ |
| Tau Ventures | VC firm | Palo Alto, CA | Pre-seed, Seed, Series A, Series B, Growth | Medtech, Healthtech, AI, B2B | New fund, Jul 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/tau-ventures/ |
| AVP | VC firm | London, United Kingdom | Series A, Series B, Growth, Late stage | Medtech, Fintech, SaaS, Insurtech | Portfolio news, Oct 2026 |  | 2026-11-04 | https://theinvestordatabase.com/investors/avp/ |
| TVM Capital Life Science | VC firm | Munich, Germany | Seed, Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, Sep 2026 |  | 2026-11-07 | https://theinvestordatabase.com/investors/tvm-capital-life-science/ |
| Valia Ventures | VC firm | London, United Kingdom | Pre-seed, Seed, Series A, Series B, Growth | Medtech, AI, Healthtech, Generalist | Portfolio news, Aug 2026 | $50M (SEC Form D, 2022) | 2026-11-05 | https://theinvestordatabase.com/investors/valia-ventures/ |
| Ansa | VC firm | New York, NY | Series A, Series B, Growth | Medtech, AI, Cybersecurity, Healthtech | New fund, May 2026 | $200M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/ansa/ |
| BIP Ventures | VC firm | Atlanta, GA | Seed, Series A, Series B | Medtech, Healthtech, Fintech, Developer Tools | New fund, Aug 2026 | $20M (SEC Form D, 2026) | 2026-11-04 | https://theinvestordatabase.com/investors/bip-ventures/ |

You are seeing 25 of 57. The full list adds 32 more investors and 296 named decision-makers.

Get all 57 investors and 296 named contacts, $49, one-time: https://theinvestordatabase.com/buy/list/series-b-medtech-investors
This page: https://theinvestordatabase.com/lists/series-b-medtech-investors/

## Method and limits
- Source: 37 of the 57 rows carry an SEC filing (Form D or Form ADV). All 57 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule: Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at Series B.
- Order: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when Series B is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Fill rates: Of 57 rows: stage 57, sector 57, fund size 45, website 57. In the paid file: named decision-makers on 52 rows, firm email on 29, LinkedIn page on 38, check size on 12.

## Questions
### How many Series B medtech investors are there?
We list 57 as of November 2026. 32 of the 57 have a fund filing or a dated deal in the last 12 months.

### Which Series B medtech investors raised a new fund in the last 12 months?
12 of the 57 have a fund filing dated in the last 12 months. The most recent on this list are IVP: Venture capital for the Exceptional (Oct 2026), Cultivation Capital (Sep 2026) and How Women Invest (Sep 2026).

### What is the typical fund size of Series B medtech investors?
The median fund size on file for this list is $81M, across the 24 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 33 do not disclose a size there.

### How do I contact Series B medtech investors?
The paid file holds 296 named decision-makers across 52 of these 57 and a firm email for 29. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.

### Where does the data on Series B medtech investors come from?
37 of the 57 rows have an SEC filing on file (Form D or Form ADV) and 20 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 7 Nov 2026 at the latest. The whole file is re-verified twice a year.